Cargando…

Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy

PURPOSE: In recent years, a variety of nanoparticles with excellent anticancer and delivery properties have emerged for cancer therapy. However, potential toxicity, high production cost and complex preparation procedures have been obstacles to their use in biomedicine. Here, we obtained cucumber-der...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tingting, Ma, Bingxiang, Lu, Shi, Zeng, Lupeng, Wang, Huaying, Shi, Wanhua, Zhou, Linying, Xia, Yaokun, Zhang, Xi, Zhang, Jing, Chen, Jinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376005/
https://www.ncbi.nlm.nih.gov/pubmed/35974872
http://dx.doi.org/10.2147/IJN.S362244
_version_ 1784768070962642944
author Chen, Tingting
Ma, Bingxiang
Lu, Shi
Zeng, Lupeng
Wang, Huaying
Shi, Wanhua
Zhou, Linying
Xia, Yaokun
Zhang, Xi
Zhang, Jing
Chen, Jinghua
author_facet Chen, Tingting
Ma, Bingxiang
Lu, Shi
Zeng, Lupeng
Wang, Huaying
Shi, Wanhua
Zhou, Linying
Xia, Yaokun
Zhang, Xi
Zhang, Jing
Chen, Jinghua
author_sort Chen, Tingting
collection PubMed
description PURPOSE: In recent years, a variety of nanoparticles with excellent anticancer and delivery properties have emerged for cancer therapy. However, potential toxicity, high production cost and complex preparation procedures have been obstacles to their use in biomedicine. Here, we obtained cucumber-derived nanovesicles (CDNVs) at high yield and low cost by simple juicing and ultracentrifugation. The anticancer effects of CDNVs were evaluated in vitro and in vivo. METHODS: Transmission electron microscope, nanoparticle tracking analysis and laser particle size analysis were used to characterize the morphology, diameter and zeta potential of CDNVs, respectively. The anticancer effects of CDNVs in vitro were evaluated by MTT and apoptosis assays. The mechanism was further explored by measuring the protein levels of signal transducer and activator of transcription 3 pathway, reactive oxygen species, cell cycle distribution and caspase activity. In-vivo anticancer efficacy was evaluated by measuring tumor volume and weight of mice in three different treatment groups (CDNVs, cucurbitacin B and PBS). RESULTS: CDNVs inhibited proliferation of human non-small cell lung cancer cells by suppressing signal transducer and activator of transcription 3 activation, generating reactive oxygen species, promoting cell cycle arrest, and activating the caspase pathway. These CDNVs exhibited strong anticancer effects both in vitro and in vivo, and reduced the rate of tumor growth without obvious toxicity to mouse visceral organs. Compared with an equivalent dose of cucurbitacin B, CDNVs exerted stronger anticancer effects in vitro and in vivo. CONCLUSION: These results demonstrate that CDNVs suppress tumor growth. This study addresses the development of cancer therapeutic drugs using plant-derived nanovesicles that are cost-efficient, simple to produce in high yields, and provide an alternative approach to drug isolation that may help advance sustainability of medicinal plants.
format Online
Article
Text
id pubmed-9376005
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93760052022-08-15 Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy Chen, Tingting Ma, Bingxiang Lu, Shi Zeng, Lupeng Wang, Huaying Shi, Wanhua Zhou, Linying Xia, Yaokun Zhang, Xi Zhang, Jing Chen, Jinghua Int J Nanomedicine Original Research PURPOSE: In recent years, a variety of nanoparticles with excellent anticancer and delivery properties have emerged for cancer therapy. However, potential toxicity, high production cost and complex preparation procedures have been obstacles to their use in biomedicine. Here, we obtained cucumber-derived nanovesicles (CDNVs) at high yield and low cost by simple juicing and ultracentrifugation. The anticancer effects of CDNVs were evaluated in vitro and in vivo. METHODS: Transmission electron microscope, nanoparticle tracking analysis and laser particle size analysis were used to characterize the morphology, diameter and zeta potential of CDNVs, respectively. The anticancer effects of CDNVs in vitro were evaluated by MTT and apoptosis assays. The mechanism was further explored by measuring the protein levels of signal transducer and activator of transcription 3 pathway, reactive oxygen species, cell cycle distribution and caspase activity. In-vivo anticancer efficacy was evaluated by measuring tumor volume and weight of mice in three different treatment groups (CDNVs, cucurbitacin B and PBS). RESULTS: CDNVs inhibited proliferation of human non-small cell lung cancer cells by suppressing signal transducer and activator of transcription 3 activation, generating reactive oxygen species, promoting cell cycle arrest, and activating the caspase pathway. These CDNVs exhibited strong anticancer effects both in vitro and in vivo, and reduced the rate of tumor growth without obvious toxicity to mouse visceral organs. Compared with an equivalent dose of cucurbitacin B, CDNVs exerted stronger anticancer effects in vitro and in vivo. CONCLUSION: These results demonstrate that CDNVs suppress tumor growth. This study addresses the development of cancer therapeutic drugs using plant-derived nanovesicles that are cost-efficient, simple to produce in high yields, and provide an alternative approach to drug isolation that may help advance sustainability of medicinal plants. Dove 2022-08-10 /pmc/articles/PMC9376005/ /pubmed/35974872 http://dx.doi.org/10.2147/IJN.S362244 Text en © 2022 Chen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Chen, Tingting
Ma, Bingxiang
Lu, Shi
Zeng, Lupeng
Wang, Huaying
Shi, Wanhua
Zhou, Linying
Xia, Yaokun
Zhang, Xi
Zhang, Jing
Chen, Jinghua
Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy
title Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy
title_full Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy
title_fullStr Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy
title_full_unstemmed Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy
title_short Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy
title_sort cucumber-derived nanovesicles containing cucurbitacin b for non-small cell lung cancer therapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376005/
https://www.ncbi.nlm.nih.gov/pubmed/35974872
http://dx.doi.org/10.2147/IJN.S362244
work_keys_str_mv AT chentingting cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy
AT mabingxiang cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy
AT lushi cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy
AT zenglupeng cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy
AT wanghuaying cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy
AT shiwanhua cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy
AT zhoulinying cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy
AT xiayaokun cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy
AT zhangxi cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy
AT zhangjing cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy
AT chenjinghua cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy